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The Epidemiology of Enterococci 
C. Chenoweth, D. Schaberg* 
The enterococci are emerging as a significant cause of nosocomiai infections, ac- 
counting for approximately 10 % of hospital acquired infectious. They are found as 
normal inhabitants of the human gastrointestinal tract, but may also colonize the 
oropharynx, vagina, perineal region and soft tissue wounds of asymtomatic patients. 
Until recently, evidence indicated that most enterococcal infections arose from 
patients' own endogenous flora. Recent studies, however, suggest that exogeneous 
acquisition may occur and that person-to-person spread, probably on the hands of 
medical personnel, may be a significant mode of transmission of resistant entero- 
cocci within the hospital. The use of broad-spectrum antibiotics, especially cepha- 
iosporins, is another major factor in the increasing incidence of enterococcal 
infections. These findings suggest that barrier precautions, as  applied with other 
resistant nosocomial pathogens, along with more judicial use of  antibiotics may be 
beneficial in preventing nosocomial spread of resistant enterococci. 
In recent years, the enterococcus has become 
recognized as a significant cause of hospital 
acquired infections (1, 2, 3). In 1984 the Centers 
for Disease Control listed the enterococcus as 
the third most commonly isolated pathogen in 
nosocomial infections in the USA, accounting 
for 10.4 % of infections (4). Enterococci were 
reported to be the cause of 14.7 % of cases of 
nosocomial urinary tract infections (UTI) and 
7.1% of cases of bacteremia. There have also 
been reports suggesting that the incidence of 
enterococcal bacteremia has increased in the 
past 20 years (3,5). Enterococci currently are 
responsible for 8 % of cases of nosocomial bac- 
teremia at the University of Michigan (Table 1). 
Whiteside et al. (5) reported that the incidence 
of bacteremia increased approximately 20 % 
yearly between 1976 and 1981. Similarly, Maki 
and Agger (3) noted that the number of cases of 
nosocomial enterococcal bacteremia increased 
markedly during the decade 1973-1983, while 
the number of community-acquired cases of 
enterococcal bacteremia remained constant. 
This is supported by the findings of Morrison 
and Wenzel (6) who showed that the rate of en- 
terococcal nosocomiaI UTI increased progres- 
sively from 12.3 to 32.3 cases per 10,000 patient 
discharges between 1975 and 1984. These studies 
clearly emphasize the increasing significance of 
the enterococci as a nosocomial pathogen. 
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Traditionally, the source of enterococcal infec- 
tions has been thought to be endogenous, aris- 
ing from the patients own flora (7, 8, 9). Recent 
evidence, however, has suggested that noso- 
comial transmission and exogenous acquisition 
of enterococci may occur (10, 11). The results of 
these studies indicate that patient-to-patient 
transfer and inter-hospital spread, well recog- 
nized in other bacterial species, can also occur 
with enterococci. 
The Agent: Microbiologic 
Characterization and Nomenclature 
Enterococci have classically belonged to the 
Lancefield group D streptococci and have been 
identified in the laboratory by their unique 
biologic properties (12). Enterococci are gram- 
positive facultative anaerobic cocci that are able 
to grow in media containing 6.5 % sodium 
chloride, 40 % bile or 0.1% methylene blue. 
They will usually survive at 60 °C for 30 min and 
can grow at extremes of pH (up to 9.6) and 
temperature (range of 10-45 °C). Enterococci 
also share the ability to hydrolyze esculin with 
other members of the group D streptococci. 
Recently, the ability of enterococci to hydrolyze 
L-pyrrolidonyt t3-naphthylamide has been used 
as part of a method for rapid screening for 
enterococci in the laboratory (13). 
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Table 1: Distribution of pathogens for nosocomial bacte- 
remia at University of Michigan Hospital in 1988. 
O rganism Percentage 
Coagulase negative staphylococci 23.7 % 
Staphylococcus aureus 15.7 % 
Candida albicans 9.6 % 
Escherichia coli 9.1% 
Enterococci 8.2 % 
Pseudomonas aeruginosa 5.9 % 
The most clinically important feature of the 
enterococci which differentiates them from non- 
enterococcal group D streptococci, is their anti- 
biotic resistance pattern. Most strains of en- 
terococci are inhibited (MIC usually 4 I~g/ml) 
but not killed by benzylpenicillins (14, 15, 16). 
Ampicillin and the ureidopenicillins are usu- 
ally active, with MICs of 1-4 txg/ml, but are not 
reliably bactericidal (I7, 18). The MICs of the 
semisynthetic penicillins, nafcillin, oxacillin 
and methicillin are much higher, around 8.5 
~tg/ml (19, 20, 21), while MICs of cephalosporins 
are even higher (17, 22). Most strains of entero- 
cocci are resistant to tetracycline, erythromycin, 
clindamycin, chloramphenicol  and sutfon- 
amides (15, 23). Many strains are reported as 
sensitive to trimethoprim/sulfamethoxazole but 
this probably represents an in vitro phenom- 
enon, since enterococci have been shown to 
escape the action of trimethoprim/sulfamethox- 
azole on addition of folinic acid (24, 25, 26). 
Vancomycin and teicoplanin, while highly 
active against enterococci, are not consistently 
bactericidal (27, 28). Enterococci are also rela- 
tively resistant to aminoglycosides, the average 
gentamicin and tobramycin MICs being 8-64 
~tg/ml (15, 29), but high-level aminoglyside 
resistance is becoming a significant problem in 
some areas (19, 11, 30, 31, 32). 
The current 1984 Bergey's Manual of Systematic 
Bacteriology lists the enterococci, including 
Streptococcus faecalis, Streptococcus faecium, 
Streptococcus avium and Streptococcus galli- 
narium, as members of the genus Streptococcus, 
Lancefield group D (33). Shortly after comple- 
tion of the section on enterococci, however, 
Schleifer and Kilpper-Balz (34) proposed the 
formation of a new genus Enterococcus based 
on DNA-DNA and DNA-RNA homology. In 
1984 Collins et al. (35) also described two other 
species that belong to this group, Enterococcus 
durans and Enterococcus malodoratus. They  
fur ther  p roposed  a new species name 
Enterococcus casseliflavus for the previously 
named Streptococcus faecium s u b s p e c i e s  
casseliflavus. Although these names were not 
incorporated into the official nomenclature 
of the 1984 Bergey's Manual, the proposals 
mentioned above were acknowledged and the 
genus Enterococcus has now been accepted by 
the scientific community. More recently, on the 
basis of DNA hybridization new species have 
been proposed including Enterococcus haire, 
Enterococcus mundtii, Enterococcus raffinosus, 
Enterococcus pseudoavium and Enterococcus 
solitarius (36, 37, 38). Using standard biochemi- 
cal tests confirmed by DNA hybridization, 
Facklam and Collins (38) recently identified all 
of the above species. Each of the strains in their 
study, except Enterococcus mundtii, have been 
isolated from human blood cultures demonstra- 
ting their potential pathogenicity for humans. 
Reservo ir s  o f  E n t e r o c o c c i  
Enterococci are normal inhabitants of the 
human gastrointestinal tract as described by 
Andrews and Harder (39), who first applied the 
name Streptococcus faecalis. Rantz and Kirby 
(40) reported that they found enterococci in 
nearly all normal human bowels. In a more 
recent study Noble (41) determined the species 
of enterococci found in the feces of normal 
neonates and adults, and hospitalized adults. He 
found Enterococcus faecalis in 48.2 % of adult 
outpatients and 80 % of adult inpatients. Enter- 
ococcus faecium was isolated from 41.3 % and 
30 % of outpatient and inpatient adults res- 
pectively, although viable counts of Entero- 
coccus faecium were on average 100-fold lower 
than those of Enterococcus faecalis. Average 
viable counts of Enterococcus faecalis were 10 ~- 
107 CFU/g compared to average counts of 104- 
105 for Enterococcus faeciurn. Neonates had a 
similar carriage rate for Enterococcus faecalis 
(48 %), Enterococcus faecium or Enterococcus 
avium not being isolated (41). 
The incidence of various enterococcal species 
in human feces has varied with the geographical 
location and diets of the human subjects. For 
example, Hill et al. (42) found in 1971 subjects 
from England, Scotland and the USA eating a 
mixed Western diet had consistently less enter- 
ococci in their feces than individuals from 
India, Japan and Uganda who ate primarily 
vegetarian diets. In his study Enterococcus 
faecium predominated in the latter group, while 
Enterococcus faecalis predominated in the 
group eating the Western diet. These findings 
were not supported by the study of Finegold et 
al. (43) in 1974 which compared the fecal flora 
of individuals of Japanese descent who were 
living in the USA. In the subjects on a 
traditional Japanese diet there was a tenfold 
higher incidence of Enterococcus faecaIis com- 
pared with subjects on a typical US diet. Other 
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early studies have emphasized the importance of 
geographic location for the incidence of 
enterococcal species in human feces. Studies 
performed in the USA, UK and Egypt have 
shown a predominance of Enterococcus faecalis 
species, Enterococcus faecium being found less 
frequently or at lower levels (43, 44). At the 
same time, studies performed on individuals 
living in Europe, India, Japan and Uganda 
showed a predominance o f  Enterococcus  
faecium in fecal samples (44). It was presumed 
that dietary and environmental factors ac- 
counted for the variation in incidence of the 
different enterococcal species. More recent 
studies from a wide variety of geographic locati- 
ons including Japan, Canada, Germany and 
Scandinavia, however, have shown a predomi- 
nance of Enterococcus faecalis, only a minority 
of subjects harboring Enterococcus faecium (45, 
46, 47). It may be concluded that in most geo- 
graphic locations Enterococus faecalis is found 
in the feces of most normal adults at a greater 
frequency and in greater quantities than Enter- 
ococcus faecium or other enterococcal species, 
but that diet and other factors may alter the 
proportions of the enterococcal species. 
Other human reservoirs of the enterococci in- 
clude the oral cavity, hepatobiliary tract and 
vagina of asymptomatic women, as well as soft 
tissue lesions and chronic decubital ulcers. 
Enterococci are found in low numbers in the 
oral cavity (48). In a study of patients with acute 
leukemia enterococci were found in 24 % of 
oral washings and/or sputum cultures upon ad- 
mission to hospital. This percentage decreased 
with antibiotic treatment however (49). Another 
study revealed enterococci in approximately 
10 % of cultures of dental plaque of various 
groups, including healthy hospital personnel 
and hemodialysis patients (50). The carriage 
rate in the vagina of asymptomatic women is 
slightly higher, ranging from 24-34 % with mean 
concentrations of 10 7 CFU/g (51, 52). Similarly, 
Gross et al. (7) found that more than 60 % of 
men in a Veterans Administration hospital had 
perineal and meatal cultures positive for enter- 
ococci. Enterococci have also been isolated in 
5 % of 501 selected cholecystectomy specimens 
(53). The major site of colonization in hospi- 
talized patients, however, is soft tissue wounds 
and ulcers. Horvitz and von Graevenitz (54) 
found that enterococci occurred in mixed cul- 
tures in many wounds but also in pure culture. 
Seventy-one percent of the pure culture came 
from wounds with no clinical evidence of in- 
fection. Although the gastrointestinal tract is 
the primary reservoir for enterococcus, the 
above studies emphasize the ability of the enter- 
ococci to colonize diverse sites, all of which 
may act as a portal of entry for the organism in 
infection. 
Mo des  o f  Transmiss ion o f  Enterococci  
Traditionally, the source of enterococcal infec- 
tions has been thought to be the endogenous 
flora of the host (7, 8, 9, 40, 55, 56). One early 
study which gave credibility to this belief was 
done by Gross et al. (7) in a Veterans Adminis- 
tration hospital during 1972-1973. The entero- 
coccus was the most common isolate from 
infected urines in this select population. All but 
one patient was male and the mean age was 63 
years. Also of note is the fact that urinary tract 
instrumentation had occurred in 30 of 34 
patients (88 %). Using antibiograms to identify 
strains of enterococci, Gross et al. (7) found no 
clustering when reviewing the positive isolates 
by location in the hospital. They then studied 
the environment of nine patients with indwel- 
ling -foley catheters and found that four had 
positive urine cultures (> 105 organisms/ml) and 
seven had positive rectal cultures. There was 
heavy contamination of the perineum, meatus 
and components of the Foley catheter as well as 
bed sheets in all the patients with positive rectal 
cultures. Cultures of hands of nursing personnel 
and physicians revealed that only 10 % were 
positive for enterococci and all but one strain 
had antibiograms different from those of the 
strains found in patients in that location. The 
authors then prospectively studied perineal and 
urine cultures of patients once the Foley 
catheter was inserted. Two patients found to 
harbor enterococci in their rectum went on to 
develop positive urine cultures with enterococci 
which had antibiograms identical to that of the 
original rectal and meatal isolates. The authors 
concluded that nosocomial enterococcal bacte- 
remia was usually caused by the patient's own 
endogenous fecal flora introduced into the 
bladder with instrumentation of the urinary 
tract and that there was no evidence of person- 
to-person spread within the hospital (7). 
These conclusions were supported by other 
studies on UTI and bacteremia which have not 
shown evidence of person-to-person spread (9, 
57). Stamm et al. (57) reviewed 265 consecutive 
epidemics of UTI reported by the Centers for 
Disease Control (CDC) between 1956 and 1979. 
They found that enterococci accounted for less 
than 1% of epidemic UTIs compared to ap- 
proximately 10 % of endemic UTIs. Similarly, 
Maki (9) reviewed the epidemiology of nos- 
ocomial bacteremia and found that enterococcal 
bacteremia was most often secondary to UTI or 
post-surgical abdominal infection. He identified 
no epidemics of enterococcal bacteremia. 
Until recently there has been very little evi- 
dence to dispute the assumption that endog- 
enous flora is the primary source of entero- 
coccal infections. One notable exception has 
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been the report of enterococcal endocarditis in 
husband and wife heroin addicts who shared 
needles and syringes. The pair developed endo- 
carditis with Enterococcus faecalis strains ex- 
hibiting identical antibiotic susceptibility pat- 
terns and biochemical profiles which strongly 
suggested transmission of enterococci from one 
spouse to the other (58). Another report of an 
exogenous source of enterococcal colonization 
came from Smith and Dayton (59) who noted an 
increased incidence of Enterococcus faecalis in 
cultures of burn wounds. The increase was 
traced to porcine xenografts contaminated with 
Enterococcus faecaIis (59). 
Previously, it has been difficult to perform epi- 
demiologic studies on enterococcal transmis- 
sion since antibiotic sensitivity patterns and 
biochemical profiles do not reliably show 
enough variation to distinguish different strains 
of Enterococcus faecalis among isolates (10, 11, 
60, 61). Analysis of .the plasmid content of 
bacteria is often more effective in differentiating 
strains. This method has been used successfully 
in epidemiologic studies of other nosocomial 
outbreaks (62). Using this method, Zervos et al. 
(10, 11) obtained results which strongly support 
exogenous acquisition and transmission of ente- 
rococci. In their first study they retrospectively 
compared patients at the University of Michigan 
Hospitals with high level gentamicin resistant 
enterococci (MIC > 2000 gg/ml) with a control 
group of patients with gentamicin sensitive ente- 
rococci (MIC < 64 gg/ml) (11). They reported a 
marked increase in gentamicin resistant or- 
ganisms between 1981 and 1984 in their hospital. 
This increase continues, over 15 % of clinical 
isolates being resistant to gentamicin in 1988 
(Table 2). Other important findings were that 
highly gentamicin resistant Enterococcus fae- 
calis infections were significantly associated 
with prior antibiotic therapy, including pre- 
operative antibiotic prophylaxis, previous sur- 
gical procedures and longer hospitalization. All 
patients with high level gentamicin resistant 
Enterococcus faecalis had received antibiotics 
in the preceding three months (94 % received 
cephalosporins, 73 % received aminoglycosi- 
des). The mean number of days of hospitaliza- 
tion prior to isolation of enterococci was much 
longer for patients with high level gentamicin 
resistant organisms (mean 25.7 days) compared 
to gentamicin sensitive strains (mean 15.2 days). 
Also, strains isolated from ten patients in a 
surgical intermediate care ward within a two- 
month period had identical plasmid content, 
transfer properties, and donor and transcon- 
jugant resistance patterns. Moreover, high level 
gentamicin resistant Enterococcus faecalis with 
the same plasmid profile as the outbreak strain 
was cultured from a door handle in the surgical 
intensive care unit suggesting at least transient 
carriage on the hands of medical personnel (11). 
This study, which suggests that nosocomial 
transmission of enterococci may occur, was sup- 
ported by a second prospective study of genta- 
micin resistant enterococci by the same authors 
(10). At the Ann Arbor Veterans Adminis- 
tration Medical Center all patients admitted to 
an index general medicine ward or surgical 
intensive care unit (SICU) over a two-month 
period were followed up with cultures. Initial 
cultures in 33 % of patients were positive for 
gentamicin resistant enterococci. All of these 
patients had been hospitalized for more than 72 
hours before entry to the study. Another 10 % 
of patients acquired high level gentamicin re- 
sistant enterococci, six after admission to the 
SICU and four on the medical ward. The six 
patients who acquired their resistant entero- 
cocci in the SICU were clustered by location 
and by the time of hospitalization. Three plas- 
mid types were found in the isolates of these six 
patients, however isolates from patients in adja- 
cent beds of the SICU as well as an isolate from 
the hands of a nurse working in that unit were 
identical in plasmid content. Another patient 
acquired a high level gentamicin resistant Ente- 
rococcus faecalis strain which was identical to a 
strain of enterococcus causing an outbreak of 
infection in patients on the surgical ward at the 
University of Michigan Hospital. Another im- 
portant finding was that patients initially colo- 
nized with high level gentamicin resistant enter- 
ococci in their perineal or rectal areas later de- 
Table 2: Frequency of isolation of high-level gentamicin resistant enterococci at University of 
Michigan Hospital, 1982-1988. 
Year Total no. of enterococci No. with high level resistance Percent 
1982 954 5 0.5 
1983 971 14 1.4 
1984 1121 58 5.2 
1985 1044 107 10.3 
1986 639 68 t0.6 
1987 833 91 10.9 
1988 672 103 15.3 
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veloped clinical infections with resistant strains; 
six developed UTI and one a wound infection 
(10). Again, acquisition of gentamicin resistant 
strains was significantly associated with prior 
systematic antibiotic therapy. 
This study documents nosocomial acquisition of 
gentamicin resistant Enterococcus faecal& and 
strongly suggests that transmission occurs from 
person to person within the hospital via tran- 
sient carriage on the hands of medical personnel 
(10). This agrees well with what is known about 
the epidemiology of resistant staphylococci (63, 
64, 65). Carriage on the hands of hospital 
personnel appears to be the most important 
mode of transmission of these organisms within 
the hospital. Inter-hospital transmission was 
also suggested in this study by the finding of a 
resistant strain of Enterococcus faecalis isolated 
in the SICU of the Ann Arbor Veterans 
Administration Hospital which was identical to 
a strain isolated from a patient cluster in the 
surgical units of the University of Michigan 
Hospital (10). Spread between the two hospitals 
may have occured by carriage on the hands of 
rotating medical students and house officers or 
by transfer of colonized patient from one 
hospital to the other . This method of inter- 
hospital spread has been suggested for other no- 
socomial pathogens, such as resistant gram-neg- 
ative rods and methicillin resistant Staphylo- 
coccus aureus (66, 67). 
These conclusions are supported by recent stud- 
ies on enterococeal infection in neonatal in- 
tensive care units (68, 69) Coudron et al. (68) 
first reported an outbreak of Enterococcus 
faecium bacteremia and meningitis among low 
birth weight babies in their neonatal intensive 
care unit. On the basis of biochemical reactions 
in rapid identification systems, the authors were 
able to identify isolates from outbreak patients 
and hands of hospital personnel (68). Luginbuhl 
et al. (69) described a similar epidemic of Enter- 
ococcus faecalis bacteremia in a neonatal in- 
tensive care unit. Two biochemical assays and 
plasmid profiles were used to identify epidemic 
strains from background nursery strains of 
enterococci.  When compared to controls 
matched for date of admission and weight, cases 
were significantly more likely to have had a 
non-umbilical central line, a longer duration of 
the central line in situ, and a bowel resection 
(69). Ano the r  nosocomial  ou tb reak  of 
gentamicin resistant beta-lactamase producing 
Enterococcus faecalis in an infant/toddler 
surgical ward was described recently E. Rhine- 
hart et al., 28th Interscience Conference on 
Antimicrobial Agents and Chemotherapy, Los 
Angeles, 1988, Abstract no. 1073). At the time 
of reporting, 23 % of patients and 25 % of 
personnel exhibited stool colonization. Case- 
control data suggested that patient colonization 
was associated with exposure to a chronically 
colonized nurse. 
These reports of exogenous acquisition and nos- 
ocomial transmission of enterococci resistant to 
gentamicin and producing or not producing t~- 
lactamase raise the question as to whether in 
patients known to harbor these organisms bar- 
rier precautions should be applied (2, 3, 10, 11). 
These techniques have been recommended and 
used for patients known to be colonized with 
multi-resistant gram-negative bacilli (67). The 
importance of the increased use of broad- 
spectrum antibiotics, particularly cephalospo- 
tins and aminoglycosides, in selecting for 
resistant enterococci in the hospital is also 
emphasized. 
Epidemiologic Aspects of Enterococcal 
Infection 
Urinary Tract Infection In the 1984 US National 
Nosocomial Infection Survey (NNIS), entero- 
cocci accounted for 14.7 % of nosocomial UTIs 
(4). The UK national survey of infection in 
hospitals in 1980 reported enterococci in 7.2 % 
of UTIs (70). The number and proportion of 
UTIs caused by enterococci appear to be in- 
creasing (6, 71). Lemoine and Hunter (71) noted 
an increase from 11% to 20 % in catheterized 
patients' urine specimens with more than 105 
organisms over the six years of their study. As 
mentioned earlier, Morrison and Wenzel (6) 
found a similar increase in UTIs caused by 
enterococci. 
Risk factors for enterococcal UTI have been 
identified as urinary tract instrumentation or 
catheterization (6, 7, 71, 72), other genitourinary 
tract pathology (6, 7), and previous use of 
antibiotics especially cephalosporin (6). One 
study noted previously showed that an increase 
in enterococcal UTI paralleled an increase in 
cephalosporin use in the hospital (6). 
The source of the enterococci, as previously 
discussed, was originally thought to be the pa-  
tients' own endogenous fecal flora, based on the 
study of Gross et al. (7). Using biochemical tests 
and antibiograms they showed that patients col- 
onized with enterococci developed positive 
urine cultures with identical enterococci after 
urinary catheterization (7). This assumption 
must be reevaluted now in the light of the recent 
study of Zervos et al. (10). These authors iden- 
tified several patients with rectal or perineal 
enterococcal colonization who later developed 
UTI or wound infections with enterococci. 
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Using antibiotic sensitivity patterns and plasmid 
profiles, however, they showed that the urinary 
tract isolate differed from the rectal or perineal 
isolate in two out of three cases, suggesting that 
colonization during catheter insertion, and not 
rectal or perineal colonization, predisposes to 
UTI (10). 
Bacteremia. Enterococci were reported in the 
1984 NNIS (4) to cause 7.1% of cases of noso- 
comial bacteremia. Again, based on a number of 
recent studies the incidence of enterococcal 
bacteremia appears to be increasing (3, 5, 73). 
Maki and Agger (3) showed that the increase in 
enterococcal bacteremia in their hospital was 
entirely due to nosocomial bacteremia since the 
incidence of community-acquired enterococcal 
bacteremia did not change during the study 
period. In two separate studies 77-78 % of cases 
of enterococcal bacteremia were hospital ac- 
quired (3, 56). 
The possible s o u r c e s o f  enterococcal bactere- 
mia include infection or colonization of the 
genitourinary, gastrointestinal and hepatobili- 
ary tracts. The most common source of entero- 
coccal bacteremia in several studies has been 
the urinary tract, accounting for 19-24 % of 
cases of enterococcemia (1, 74, 75). Ledger et al. 
(76) have reported enterococcus as a frequent 
cause of secondary bacteremia in patients in an 
obstetric and gynecologic ward with endome- 
tritis, postoperative wound infections, pyelone- 
phritis and other gynecologic infections. Other 
major sources of enterococcal bacteremia in- 
clude the hepatobiliary tract and intra-abdom- 
inal infections (1, 3, 74, 74, 77, 78, 79). Intravas- 
cular catheters were a significant source of 
enterococcal bacteremia in Maki and Agger's 
recent study (3). Finally, soft tissue infections 
account for another major source of enterococ- 
cal bacteremia (3, 74, 75). Given the nature of 
the most common sources listed above, it is not 
surprising that enterococcal bacteremia is fre- 
quently polymicrobial (up to 42 % in some 
cases) (1, 3, 74, 75, 77, 78). 
Several recent reviews of enterococcal bactere- 
mia have listed burn wounds as a significant 
source of enterococcemia (1, 3). Another study 
has reported a large increase in cases of entero- 
coccal burn bacteremia associated with a high 
mortality rate (80). Maki and Agger (3) re- 
ported that 11 of their 25 patients with entero- 
coccal burn wound bacteremia had received an 
oral prophylactic antibiotic regimen consisting 
of erythromycin and neomycin. Ninety percent 
of isolates from these patients were resistant to 
erythromycin, again emphasizing the selective 
pressure of antibiotics in the increasing inci- 
dence of enterococcal bacteremia. 
Neonatal baeteremia and sepsis have also re- 
cently been reported to be increasing in inci- 
dence and clinical significance. Siegel and 
McCracken (81) reported an incidence rate of 
0.6 cases per 1,000 live births at their institute 
between 1974 and 1977. A retrospective review 
of neonatal infections performed by Buchino et 
al. (82) identified nine cases of enterococcal 
sepsis between 1970 and 1976. The epidemiology 
of endemic enterococcal bacteremia in neonates 
has not been fully investigated. In two recent 
outbreaks of neonatal  enterococcal sepsis 
caused by a single organism, however, there was 
evidence of exogenous acquisition and noso- 
comial transmission of the enterococcal strain 
(68, 69). 
Endocarditis. Enterococcal endocarditis occurs 
much less frequently than bacteremia caused by 
the same organism. Recent reviews have re- 
ported the percentage of patients with entero- 
coccal endocarditis identified among patients 
with enterococcal bacteremia to be 8-32 % (1, 3, 
75). It has been estimated that enterococci cause 
5-15 % of cases of endocarditis (8, 83). Entero- 
coccal endocarditis is uncommon in infancy and 
early childhood (84, 85). Patients with entero- 
coccal endocarditis are predominantly male, 
with an average 9 f 56-59 years, although one 
recent study reported an average age of 65 years 
(86-88}. Women with endocardidits tend to be 
much younger, with an average age of 35-37 
years (86, 87). 
Although a source of enterococci is not found 
in most cases, the genitourinary tract is impli- 
cated in those patients where a source is sug- 
gested. Mandell et al. (87) found that 50 % of 
men had a history of preceding enterococcal 
UTI or genitourinary tract instrumentation and 
that 43 % of women had a history of childbirth 
or abortion in the preceding three months. 
Patients with underlying valvular heart disease 
are at greatest risk of acquiring enterococcal 
endocarditis (3, 87, 89, 90), although 42 % of pa- 
tients in Mandell's series had no underlying 
heart disease (87). Other risk factors for 
endocarditis identified by Maki and Agger (3) 
in their series on enterococcal bacteremia in- 
clude community acquired enterococcemia and 
lack of an extracardiac source of infection. 
Bacteremia with enterococci as sole isolate also 
significantly correlated with endocarditis, while 
no patients with polymicrobial sepsis had endo- 
carditis. 
Intravenous drug users are the final group of pa- 
tients at risk for enterococcal endocarditis (58, 
91). In one series enterococci caused 55 % of 
cases of narcotic-associated endocarditis during 
the 54-month study period. Patients in this study 
were younger and less often had a history of 
underlying heart disease or genitourinary tract 
abnormalities than non-addict patients reported 
in earlier series (91). 
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lntra-Abdorninal Infection. Al though  en te ro -  
cocci can be isolated in a significant number  of 
in t ra -abdominal  infections, their  role in these 
infections is controvers ia l  (92). In the experi-  
m e n t a l  i n t r a - a b d o m i n a l  abscess  mode l  o f  
Onderdonk  et al. (93) enterococci alone caused 
no abscess format ion  or mortality.  When given 
with anaerobes  such as Bacteroides fragilis or  
Fusobacterium varium, however ,  the combi-  
nat ion caused abscesses in 89-95 % of cases. 
These  au thors  suggest  that  en terococci  are 
p a t h o g e n i c  in these  infec t ions  only syner-  
gistically with anaerobes .  Fu r the rmore ,  anti- 
biotic regimens with no activity against entero-  
cocci have been shown to be  effective in treating 
in t ra -abdominal  infections, even when entero-  
cocci are grown (94, 95). Despi te  such evidence 
severa l  reviews on bac t e remia  have revealed  
that  the source  of enterococcal  bac te remia  is 
in t ra-abdominal  infection in a significant num- 
ber  of cases (1, 3, 80). There  are also several  
clinical reports  of enterococci occurring as sole 
isolates in in t ra -abdominal  infections (79, 96, 
97). The  presence  of foreign bodies,  such as 
dialysis catheters ,  and the use of  pr ior  anti- 
biotics appea r  to be predisposing factors  for 
en te rococca l  i n t r a - abdomina l  infect ions  (96, 
98). 
Other Miscellaneous Enterococcal Infections. 
Enterococc i  are a ra re  cause of meningit is  in 
hea l t hy  indiv iduals .  As  discussed ear l ie r ,  
neonates  are at risk for enterococcal  sepsis and 
meningi t i s  (68, 69, 81, 82). Risk  fac to r s  for  
meningit is  have  been  identified as anatomical  
central  nervous system defects or pr ior  neuro- 
surgical p rocedures  such as shunt p lacement ,  
especial ly if the shunt  drains into the peri-  
t oneum (99, 100), O the r  risk factors  include 
enterococcal  U T I  or endocarditis (99), however 
one recent  case repor t  described enterococcal  
meningit is  in a man whose only predisposing 
fac tor  was s teroid  t he rapy  for  chronic  ob- 
structive pulmonary  disease (101). 
Enterococci  are rarely implicated as the cause 
of lower  resp i ra tory  t ract  infections. The  ex- 
ceptions are a few cases of enterococcal  pneu-  
monia  repor ted  in pat ients  being t reated with 
b road-spec t rum antibiotics. These reports  sug- 
gest that more  cases of enterococcal pneumonia  
may arise in the future with widespread cepha- 
losporin use (102). 
C o n c l u s i o n  
The  enterococci produce disease in a number  of 
sites but  are especially c o m m o n  as causes of 
deep  soft-t issue infection, bac te remia  and uri- 
nary tract  infection. The majori ty of  infections 
appear  to be  endogenous but cross-infection has 
b e e n  d o c u m e n t e d  in the hospital ,  especial ly  
with resistant  strains. The enterococci  seem to 
be readly selected for the use of broad-spect rum 
antimicrobial  agents, especially the newer ceph- 
alosporins.  As a consequence of this selection 
coupled with the emergence  of strains highly 
resistant to aminoglycosides and more  recently 
vancomycin ,  the enterococci  are emerging as 
p rob lem pathogens  within hospitals. 
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